Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $571.00 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $133.82 | 16 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $108.61 | 4 | $0 (2017) |
| Lilly USA, LLC | $65.14 | 5 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $63.43 | 4 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $46.48 | 4 | $0 (2017) |
| Allergan Inc. | $29.23 | 2 | $0 (2017) |
| Novo Nordisk Inc | $29.12 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.70 | 1 | $0 (2017) |
| Amgen Inc. | $15.14 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $14.97 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $571.00 | 44 | PFIZER INC. ($133.82) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2017 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/20/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 09/11/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/08/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: DIABETES | ||||||
| 09/07/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Endocrinology | ||||||
| 08/31/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 08/29/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: DIABETES | ||||||
| 08/15/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/10/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: DIABETES | ||||||
| 08/07/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 08/07/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $0.35 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 08/04/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: VACCINES | ||||||
| 08/04/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: VACCINES | ||||||
| 08/03/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Diabetes | ||||||
| 07/20/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/04/2017 | GlaxoSmithKline, LLC. | INFANRIX (Biological), KINRIX, PEDIARIX | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: VACCINES | ||||||
| 06/26/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: VACCINES | ||||||
| 06/23/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: VACCINES | ||||||
| 06/22/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/19/2017 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/09/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Opioid Induced Constipation | ||||||
| 05/18/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 484 | 785 | $132,267 | $49,460 |
| 2022 | 9 | 576 | 820 | $131,786 | $50,493 |
| 2021 | 7 | 412 | 618 | $95,080 | $37,685 |
| 2020 | 9 | 512 | 848 | $109,585 | $36,663 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 386 | $93,026 | $31,644 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 98 | $16,072 | $5,500 | 34.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 24 | 29 | $11,832 | $4,481 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $5,865 | $2,899 | 49.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $2,698 | $2,644 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $1,560 | $1,178 | 75.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 102 | 154 | $1,078 | $1,056 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 17 | $136.00 | $57.97 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 284 | $68,444 | $23,947 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 74 | 74 | $18,870 | $9,415 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 155 | $25,420 | $8,501 | 33.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 23 | $9,384 | $3,617 | 38.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 38 | $2,698 | $2,605 | 96.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 40 | $1,560 | $1,132 | 72.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 24 | 25 | $4,125 | $732.33 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 113 | 163 | $1,141 | $482.70 | 42.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 18 | $144.00 | $61.91 | 43.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 223 | $53,743 | $19,179 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 66 | 66 | $16,830 | $8,525 | 50.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 123 | $20,172 | $7,122 | 35.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 29 | 29 | $2,059 | $1,893 | 91.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 32 | 32 | $1,248 | $524.80 | 42.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 84 | 132 | $924.00 | $396.00 | 42.9% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 13 | $104.00 | $45.24 | 43.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 121 | 255 | $41,820 | $11,660 | 27.9% |
About Dr. James Bernheisel, MD
Dr. James Bernheisel, MD is a Family Medicine healthcare provider based in Mountville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669413498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Bernheisel, MD has received a total of $571.00 in payments from pharmaceutical and medical device companies, with $571.00 received in 2017. These payments were reported across 44 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($571.00).
As a Medicare-enrolled provider, Bernheisel has provided services to 1,984 Medicare beneficiaries, totaling 3,071 services with total Medicare billing of $174,302. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mountville, PA
- Active Since 06/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1669413498
Products in Payments
- FARXIGA (Drug) $86.92
- TRULICITY (Drug) $65.14
- XARELTO (Drug) $63.43
- PREVNAR - 13 (Biological) $40.38
- Victoza (Drug) $29.12
- CHANTIX (Drug) $28.35
- LYRICA (Drug) $27.42
- TOUJEO (Drug) $25.14
- VIAGRA (Drug) $20.43
- LINZESS (Drug) $18.47
- ELIQUIS (Drug) $17.24
- JARDIANCE (Drug) $15.70
- Prolia (Biological) $15.14
- INFANRIX (Biological) $14.97
- AFREZZA (Drug) $12.93
- ENTRESTO (Drug) $12.42
- Movantik (Drug) $12.08
- PRALUENT ALIROCUMAB INJECTION (Biological) $11.93
- SYMBICORT (Drug) $11.14
- PRALUENT (Drug) $11.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.